LIPOCINE INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
LIPOCINE INC. (LPCN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $10.11 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-07
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $8.69M, a 152.92% increase year-over-year.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $1.43M, a 145.32% increase year-over-year.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $2.83M.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$3.62M.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $3.23M.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$25.02M.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$38.36K.
- LIPOCINE INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$1.21K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | $8.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $10.11M 10-Q · filed 2017-08-07 | $12.94M derived: sum of 3 quarters · filed 2017-08-07 | $9.33M derived: sum of 4 quarters · filed 2017-08-07 | |
| 2017-03-31 | $1.43M 10-Q · filed 2017-05-08 | $4.26M derived: sum of 2 quarters · filed 2017-05-08 | $640.48K derived: sum of 3 quarters · filed 2017-05-08 | $4.07M derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$787.42K derived: sum of 2 quarters · filed 2017-03-06 | $2.65M derived: sum of 3 quarters · filed 2017-08-07 | $3.23M 10-K · filed 2017-03-06 | |
| 2016-09-30 | -$3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$182.46K derived: sum of 2 quarters · filed 2017-08-07 | $399.60K 10-Q · filed 2016-11-08 | -$606.64K derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-06-30 | $3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $4.02M 10-Q · filed 2017-08-07 | $3.01M derived: sum of 3 quarters · filed 2017-08-07 | -$5.86M derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-03-31 | $582.06K 10-Q · filed 2017-05-08 | -$424.18K derived: sum of 2 quarters · filed 2017-05-08 | -$9.30M derived: sum of 3 quarters · filed 2017-05-08 | -$24.42M derived: sum of 4 quarters · filed 2017-05-08 | |
| 2015-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$9.88M derived: sum of 2 quarters · filed 2017-03-06 | -$25.01M derived: sum of 3 quarters · filed 2017-03-06 | -$25.02M 10-K · filed 2017-03-06 | |
| 2015-09-30 | -$8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$24.00M derived: sum of 2 quarters · filed 2016-11-08 | -$24.01M 10-Q · filed 2016-11-08 | -$24.05M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-06-30 | -$15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$15.14M 10-Q · filed 2016-08-09 | -$15.14M 10-Q · filed 2015-08-11 | -$15.18M derived: sum of 3 quarters · filed 2017-03-06 | -$15.20M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | -$13.23K 10-Q · filed 2016-05-09 | -$51.56K derived: sum of 2 quarters · filed 2017-03-06 | -$70.97K derived: sum of 3 quarters · filed 2017-03-06 | -$49.73K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2014-12-31 | -$38.33K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$57.74K derived: sum of 2 quarters · filed 2017-03-06 | -$36.49K derived: sum of 3 quarters · filed 2017-03-06 | -$38.36K 10-K · filed 2017-03-06 | |
| 2014-09-30 | -$19.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.83K derived: sum of 2 quarters · filed 2015-11-12 | -$33.00 10-Q · filed 2015-11-12 | -$33.00 derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $21.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $19.38K 10-Q · filed 2015-08-11 | $19.38K derived: sum of 3 quarters · filed 2015-08-11 | $19.38K derived: sum of 4 quarters · filed 2015-08-11 | |
| 2014-03-31 | -$1.87K 10-Q · filed 2015-05-07 | -$1.87K derived: sum of 2 quarters · filed 2015-05-07 | -$1.87K derived: sum of 3 quarters · filed 2015-05-07 | -$1.87K derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | -$1.21K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | -$1.21K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$1.21K 10-Q · filed 2014-08-13 | |||
| 2013-03-31 | -$1.21K 10-Q · filed 2014-05-13 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2012-10-26 | $0.00 10-Q · filed 2012-10-26 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |